Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma

BACKGROUND: Checkpoint inhibitors (CPIs) are thought to be effective against cutaneous melanoma in part because of the large burden of somatic mutations (neoantigens) generated from exposure to ultraviolet radiation. However, rare melanoma subtypes arising from acral skin, mucosal surfaces, and the...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Immunother Cancer
Hlavní autoři: Klemen, Nicholas D., Wang, Melinda, Rubinstein, Jill C., Olino, Kelly, Clune, James, Ariyan, Stephan, Cha, Charles, Weiss, Sarah A., Kluger, Harriet M., Sznol, Mario
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2020
Témata:
Short Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7103823/
https://ncbi.nlm.nih.gov/pubmed/32209601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000341
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky